Evolus Inc
F:EVL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Evolus Inc
F:EVL
|
US |
|
A
|
Altria Group Inc
F:PHM7
|
US |
|
Taskus Inc
NASDAQ:TASK
|
US |
|
B
|
Bio-Techne Corp
SWB:TE1
|
US |
|
S
|
Swiss Re AG
SWB:SR9
|
CH |
|
Credit Agricole SA
F:XCA
|
FR |
|
S
|
Seven & i Holdings Co Ltd
DUS:S6M
|
JP |
|
Axalta Coating Systems Ltd
NYSE:AXTA
|
US |
|
C
|
Coinbase Global Inc
BMV:COIN
|
US |
|
A
|
Axon Enterprise Inc
DUS:TCS
|
US |
Wall St Price Targets
EVL Price Targets Summary
Evolus Inc
According to Wall Street analysts, the average 1-year price target for EVL is 14.73 EUR with a low forecast of 9.944 EUR and a high forecast of 20.676 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EVL's stock price target?
Price Target
14.73
EUR
According to Wall Street analysts, the average 1-year price target for EVL is 14.73 EUR with a low forecast of 9.944 EUR and a high forecast of 20.676 EUR.
What is the Revenue forecast for Evolus Inc?
Projected CAGR
17%
The compound annual growth rate for Revenue over the next 7 years is 17%.
What is the Gross Profit forecast for Evolus Inc?
Projected CAGR
18%
The compound annual growth rate for Gross Profit over the next 7 years is 18%.
